Haruhito Azuma

A novel machine-learning model using nuclear features to predict upper tract urothelial carcinoma recurrence

Abstract Upper-tract urothelial carcinoma (UTUC) is rare, constitutes < 5% of urothelial cancers, and, given its insidious clinical presentation, is typically diagnosed at advanced stages; post-radical nephroureterectomy recurrence remains challenging. Postoperative management is...

Integrated Analysis of HER2 Expression and ERBB2 Alterations in Bladder Cancer

ABSTRACT Human epidermal growth factor receptor 2 (HER2) has emerged as a potential therapeutic target in bladder cancer (BC), particularly with the advent of next‐generation antibody–drug conjugates (ADCs) like trastuzumab deruxtecan (T‐DXd). However, the complex relationship be...